After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Recently, Yahoo Finance discussed the stock, revealing that BioAtla to Participate in the 42nd Annual J.P. Morgan Healthcare Conference.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
As a NASDAQ listed company, BCAB falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of BioAtla Inc is $136.23M. A total of 0.54 million shares were traded on the day, compared to an average of 502.86K shares.
Insider Activity
Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, BCAB has seen 1 BUY and 0 SELL insider trades, representing the acquisition of 4,000 and the disposition of 0 shares. Over the last 12 months, there were 9 BUYs and 35 SELLs from insiders. Insiders purchased 60,468 shares during that period but sold 36,736.
In the most recent transaction, MCBRINN SYLVIA bought 4,000 shares of BCAB for 2.33 per share on Dec 26. After the transaction, the Director now owns 15,125 company shares. In a previous transaction on Dec 20, SHORT JAY M PHD bought 50,000 shares at 2.14 per share. BCAB shares that Chief Executive Officer owns now total 1,439,283.
Among the insiders who bought shares, STEINMAN LAWRENCE acquired of 20,000 shares on Dec 19 at a per-share price of $2.05. This resulted in the Director holding 38,459 shares of BCAB after the transaction. In another insider transaction, Vasquez Christian bought 7,495 shares at $2.04 per share on Dec 19. Company shares held by the insider now total 115,659.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, BCAB has a high of $4.07 and a low of $1.24.
As of this writing, BCAB has an earnings estimate of -$0.79 per share for the current quarter. EPS was calculated based on a consensus of 4 estimates, with a high estimate of -$0.71 per share and a lower estimate of -$1. The company reported an EPS of -$0.75 in the last quarter, which was -17.20% lower than expectations of -$0.64.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. BCAB’s latest balance sheet shows that the firm has $244.98M in Cash & Short Term Investments as of fiscal 2021. There were $5.37M in debt and $19.81M in liabilities at the time. Its Book Value Per Share was $1.98, while its Total Shareholder’s Equity was $210.82M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BCAB is Buy with a score of 5.00.
